These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24844369)

  • 21. Treatment of human contamination with plutonium and americium: would orally administered Ca- or Zn-DTPA be effective?
    Taylor DM; Hodgson SA; Stradling N
    Radiat Prot Dosimetry; 2007; 127(1-4):469-71. PubMed ID: 17556346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of an Acellular Assay to Study Interactions between Actinides and Biological or Synthetic Ligands.
    Van der Meeren A; Berthomieu C; Moureau A; Defrance M; Griffiths NM
    Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ustur whole body case 0269: demonstrating effectiveness of i.v. CA-DTPA for Pu.
    James AC; Sasser LB; Stuit DB; Glover SE; Carbaugh EH
    Radiat Prot Dosimetry; 2007; 127(1-4):449-55. PubMed ID: 18227077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decorporation approach following rat lung contamination with a moderately soluble compound of plutonium using local and systemic Ca-DTPA combined chelation.
    Grémy O; Tsapis N; Bruel S; Renault D; Van der Meeren A
    Radiat Res; 2012 Sep; 178(3):217-23. PubMed ID: 22799632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chelation Modeling: The Use of Ad Hoc Models and Approaches to Overcome a Dose Assessment Challenge.
    Dumit S; Bertelli L; Klumpp JA; Poudel D; Waters TL
    Health Phys; 2020 Feb; 118(2):193-205. PubMed ID: 31833972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting of diethylene triamine pentaacetic acid encapsulated in liposomes to rat liver: an effective strategy to prevent bone deposition and increase urine elimination of plutonium in rats.
    Phan G; Ramounet-Le Gall B; Manceau J; Fanet M; Benech H; Fritsch P; Fattal E; Deverre JR
    Int J Radiat Biol; 2004 Jun; 80(6):413-22. PubMed ID: 15362694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacies of LICAM(C) and DTPA for the decorporation of inhaled transportable forms of plutonium and americium from the rat.
    Stradling GN; Stather JW; Gray SA; Moody JC; Ellender M; Hodgson A
    Hum Toxicol; 1986 Mar; 5(2):77-84. PubMed ID: 3514430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A comparative evaluation of the efficacy of different methods for the decorporation of plutonium from the respiratory organs].
    Liubchanskiĭ ER; Sokhranich AL; Sokol'nikov ME
    Radiats Biol Radioecol; 1997; 37(1):105-10. PubMed ID: 9102121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modelling of bioassay data from a Pu wound treated by repeated DTPA perfusions: biokinetics and dosimetric approaches.
    Fritsch P; Grappin L; Guillermin AM; Fottorino R; Ruffin M; Mièle A
    Radiat Prot Dosimetry; 2007; 127(1-4):120-4. PubMed ID: 17562647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative decorporation efficacy of 3,4,3-LIHOPO, 4,4,4-LIHOPO and DTPA after contamination of rats with soluble forms of 238Pu and 233U.
    Ramounet-Le Gall B; Grillon G; Rateau G; Burgada R; Bailly T; Fritsch P
    Radiat Prot Dosimetry; 2003; 105(1-4):535-8. PubMed ID: 14527023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second-order Kinetics of DTPA and Plutonium in Rat Plasma.
    Miller G; Poudel D; Klumpp JA; Guilmette RA; Melo D
    Radiat Res; 2018 Jan; 189(1):64-67. PubMed ID: 29140164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delivery of DTPA through Liposomes as a Good Strategy for Enhancing Plutonium Decorporation Regardless of Treatment Regimen.
    Grémy O; Miccoli L; Lelan F; Bohand S; Cherel M; Mougin-Degraef M
    Radiat Res; 2018 May; 189(5):477-489. PubMed ID: 29528770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced decorporation of plutonium by DTPA encapsulated in small PEG-coated liposomes.
    Phan G; Le Gall B; Grillon G; Rouit E; Fouillit M; Benech H; Fattal E; Deverre JR
    Biochimie; 2006 Nov; 88(11):1843-9. PubMed ID: 16860919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct lung delivery of a dry powder formulation of DTPA with improved aerosolization properties: effect on lung and systemic decorporation of plutonium.
    Gervelas C; Serandour AL; Geiger S; Grillon G; Fritsch P; Taulelle C; Le Gall B; Benech H; Deverre JR; Fattal E; Tsapis N
    J Control Release; 2007 Mar; 118(1):78-86. PubMed ID: 17241685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-body distribution of plutonium in rats for different routes of exposure.
    Weber W; Doyle-Eisele M; Melo DR; Guilmette RA
    Int J Radiat Biol; 2014 Nov; 90(11):1011-8. PubMed ID: 24552148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reducing the cancer risk of 239Pu by chelation therapy.
    Jones CW; Mays CW; Taylor GN; Lloyd RD; Packer SM
    Radiat Res; 1986 Sep; 107(3):296-306. PubMed ID: 3749464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A recycling model of the biokinetics of systemic tellurium.
    Giussani A
    Int J Radiat Biol; 2014 Nov; 90(11):1114-8. PubMed ID: 25012782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of DTPA treatments following the injection of particulate plutonium.
    Bruenger FW; Taylor DM; Taylor GN; Lloyd RD
    Int J Radiat Biol; 1991 Nov; 60(5):803-18. PubMed ID: 1680951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chelation therapy with 3,4,3-Li(1,2-HOPO) after pulmonary exposure to plutonium in rats.
    Grémy O; Devilliers K; Miccoli L
    Chem Biol Interact; 2023 Jun; 378():110488. PubMed ID: 37054935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An analysis of a puncture wound case with medical intervention.
    Bailey BR; Eckerman KF; Townsend LW
    Radiat Prot Dosimetry; 2003; 105(1-4):509-12. PubMed ID: 14527019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.